HEB

Satellite Sessions

June 5 | 12:30-14:00

Novartis Israel | June 5 | 12:30-14:00

Title: Innovation in Cardiology – Breaking the Boundaries of Traditional Cardiology

Click here to view agenda.

Novo Nordisk - Obesity | June 5 | 12:30-14:00

Title: GLP-1 RA – New insights in obesity and CVD

Click here to view agenda.

Medtronic | June 5 | 12:30-14:00

Title: Innovations in treatment of Arrythmia’s- From Cardiology in the community to Electrophysiology

Click here to view agenda.

Pharma Clinical | June 5 | 12:30-14:00

Title: New Challenges in Heart Failure Treatment

Click here to view agenda.

June 6 | 12:30-14:00

Pfizer Pharmaceuticals Israel | June 6 | 12:30-14:00

Title: Idiopathic heart failure or undiagnosed ATTR-CM? Making an early and accurate diagnosis

Click here to view agenda.

Novo Nordisk - Diabetes | June 6 | 12:30-14:00

Title: New frontiers in ASCVD with GLP-1 in T2D patients

Click here to view agenda.

AstraZeneca (Israel) | June 6 | 12:30-14:00

Title: A new era for cardiorenal patients – Exploring the role of SGLT2i in clinical practice

Click here to view agenda.

Abbott Laboratories | June 6 | 12:30-14:00

Title: From TAVI to Mitral and back – Nurse & Technician satellite at IHS

Click here to view agenda.

Supported by a Non-Restricted Grant by Edwards Lifesciences | June 6 | 12:30-14:00

Title: Tricuspid valve disease and transcatheter interventions

Click here to view agenda.

KEEP ME UPDATED

Contact

Ortra Ltd. 94 Yigal Alon St. P.O.Box 9352 Tel Aviv 6109202, Israel

Tel: +972-3-6384444
Fax: +972-3-6384455
Email: israelheart@ortra.com